Cytomegalovirus (CMV) infection exists in 50-80% of the world’s
population in clinically undetected form due to their immunocompetent
status. Here we report a case of a 42-year-old COVID-19 patient with no
past medical history, who received tocilizumab, which led to a massive
lower gastrointestinal bleeding not responded to medical management.